SCHEMBL30093058

SCHEMBL30093058

CCOc1cccc(-c2cccc(N)c2)c1

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.79
TP53 P04637 1/20 0.79
NOTUM Q6P988 1/20 0.56
MAP4K4 O95819 3/20 0.56
RXRA P19793 1/20 0.55
RXRB P28702 1/20 0.55
TSHR P16473 2/20 0.53
TDP1 Q9NUW8 2/20 0.51
KDM4E B2RXH2 1/20 0.51
GAA P10253 1/20 0.51
MAPT P10636 1/20 0.51
THRB P10828 1/20 0.51
MAOA P21397 1/20 0.50
FGFR1 P11362 1/20 0.50
FGFR2 P21802 1/20 0.50
FGFR3 P22607 1/20 0.50
BRD4 O60885 1/20 0.49
BRD2 P25440 1/20 0.49
CREBBP Q92793 1/20 0.49
MAOB P27338 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3793225 1.00 CYP3A4 (0.79) CYP3A4TP53NOTUMMAP4K4RXRA
SCHEMBL3786792 0.89 CYP3A4 (0.68) CYP3A4TP53NOTUMMAP4K4RXRA
SCHEMBL112380 0.88 CYP3A4 (1.00) CYP3A4TP53NOTUMMAP4K4TSHR
SCHEMBL29371541 0.88 CYP3A4 (1.00) CYP3A4TP53NOTUMMAP4K4TSHR
SCHEMBL29426410 0.88 RXRA (0.66) CYP3A4TP53NOTUMMAP4K4RXRA
SCHEMBL9260410 0.88 RXRA (0.66) CYP3A4TP53NOTUMMAP4K4RXRA
SCHEMBL978718 0.87 TP53 (0.65) CYP3A4TP53MAP4K4RXRARXRB
SCHEMBL1337788 0.87 TP53 (0.65) CYP3A4TP53NOTUMMAP4K4RXRA
Hydrochloric Acid SCHEMBL2871122 0.86 CYP3A4 (0.96) CYP3A4TP53NOTUMMAP4K4TSHR
SCHEMBL29012837 0.86 RXRA (0.64) CYP3A4TP53NOTUMMAP4K4RXRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115397806-A Aryl and heteroaryl compounds and their therapeutic use in conditions associated with altered activity of galactocerebrosidase 增益治疗股份有限公司 2022-11-25 CN disclosed